We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Shire Pharmaceuticals Ireland Limited

Miesian Plaza, 50-58 Baggot Street, Lower, Dublin 2, Ireland
Medical Information Direct Line: +44 800 055 6614 (outside of Ireland)
Medical Information Direct Line: +353 1 800 818016
Medical Information e-mail: medinfoemea@shire.com
Customer Care direct line: +44 (0)1256 894 107
Patient Information Leaflet last updated on medicines.ie: 15/12/2017
PIL Equasym XL 10, 20 & 30mg Modified Release Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15/12/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
Updated on 06/03/2012 and displayed until 15/12/2017
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/02/2011 and displayed until 06/03/2012
Reasons for adding or updating:
  • Change to storage instructions
  • Change to further information section
  • Change to date of revision
Updated on 25/11/2010 and displayed until 14/02/2011
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to further information section
  • Change to date of revision
  • Change to improve clarity and readability
  • Change due to harmonisation of patient information leaflet
Updated on 17/08/2009 and displayed until 25/11/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change to marketing authorisation holder
Updated on 26/08/2008 and displayed until 17/08/2009
Reasons for adding or updating:
  • Addition of manufacturer
  • PIL retired pending re-submission
Updated on 27/04/2007 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 21/02/2007 and displayed until 27/04/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Methylphenidate Hydrochloride